{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:17:12Z","timestamp":1782775032318,"version":"3.54.5"},"reference-count":47,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Woodruff Health Sciences Center of Emory University","award":["Synergy Award"],"award-info":[{"award-number":["Synergy Award"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01HD066059"],"award-info":[{"award-number":["1R01HD066059"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32HL130025"],"award-info":[{"award-number":["T32HL130025"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["CDC-U01DP005119"],"award-info":[{"award-number":["CDC-U01DP005119"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["CDC-U01DP006488"],"award-info":[{"award-number":["CDC-U01DP006488"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Lupus Sci Med"],"accepted":{"date-parts":[[2020,10,1]]},"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Women with SLE may experience ovarian insufficiency or dysfunction due to treatment or disease effects. Anti-M\u00fcllerian hormone (AMH), a marker of ovarian reserve, has been examined in small populations of women with SLE with conflicting results. To date, these studies have included very few African-American women, the racial\/ethnic group at greatest risk of SLE.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We enrolled African-American women aged 22\u201340 years diagnosed with SLE after age 17 from the Atlanta Metropolitan area. Women without SLE from the same area were recruited from a marketing list for comparison. AMH was measured in serum using the Ansh Labs assay (Webster, Texas, USA). We considered AMH levels &lt;1.0\u2009ng\/mL and AMH &lt;25th percentile of comparison women as separate dichotomous outcomes. Log-binomial regression models estimating prevalence ratios were adjusted for age, body mass index and hormonal contraception use in the previous year.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Our sample included 83 comparison women without SLE, 68 women with SLE and no history of cyclophosphamide (SLE\/CYC\u2212) and 11 women with SLE and a history of cyclophosphamide treatment (SLE\/CYC+). SLE\/CYC+ women had a greater prevalence of AMH &lt;1.0\u2009ng\/mL compared with women without SLE (prevalence ratio (PR): 2.90, 95% CI: 1.29 to 6.51). SLE\/CYC\u2212 women were also slightly more likely to have AMH &lt;1.0\u2009ng\/mL (PR: 1.62, 95%\u2009CI: 0.93 to 2.82) than comparison women. Results were similar when considering AMH &lt;25th percentile by age of comparison women.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Treatment with CYC is associated with low AMH in African-American women with SLE. SLE itself may also be associated with reduced AMH, but to a lesser extent.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/lupus-2020-000439","type":"journal-article","created":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T15:40:13Z","timestamp":1604245213000},"page":"e000439","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":12,"title":["Anti-M\u00fcllerian hormone in African-American women with systemic lupus erythematosus"],"prefix":"10.1136","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4927-8786","authenticated-orcid":false,"given":"Meghan","family":"Angley","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica B","family":"Spencer","sequence":"additional","affiliation":[{"name":"Division of Reproductive Endocrinology and Infertility, Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2361-0787","authenticated-orcid":false,"given":"S Sam","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA"},{"name":"Department of Medicine, Division of Rheumatology, Emory University School of Medicine, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope P","family":"Howards","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,11,1]]},"reference":[{"key":"2025091512551693000_7.1.e000439.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2008.10.007"},{"key":"2025091512551693000_7.1.e000439.2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket322"},{"key":"2025091512551693000_7.1.e000439.3","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N Engl J Med Overseas Ed"},{"key":"2025091512551693000_7.1.e000439.4","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1177\/0961203317693096","article-title":"Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years","volume":"26","author":"Taraborelli","year":"2017","journal-title":"Lupus"},{"key":"2025091512551693000_7.1.e000439.5","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmt062"},{"key":"2025091512551693000_7.1.e000439.6","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/aogs.13334","article-title":"The use of anti-M\u00fcllerian hormone for controlled ovarian stimulation in assisted reproductive technology, fertility assessment and -counseling","volume":"97","author":"Pilsgaard","year":"2018","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2025091512551693000_7.1.e000439.7","doi-asserted-by":"crossref","first-page":"e1862","DOI":"10.1210\/clinem\/dgz283","article-title":"Antimullerian Hormone and Impending Menopause in Late Reproductive Age: The Study of Women\u2019s Health Across the Nation","volume":"105","author":"Finkelstein","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2025091512551693000_7.1.e000439.8","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/humrep\/dey077","article-title":"Anti-M\u00fcllerian hormone levels and incidence of early natural menopause in a prospective study","volume":"33","author":"Bertone-Johnson","year":"2018","journal-title":"Hum Reprod"},{"key":"2025091512551693000_7.1.e000439.9","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dev145"},{"key":"2025091512551693000_7.1.e000439.10","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s12020-018-1783-1","article-title":"Anti-M\u00fcllerian hormone serum levels in systemic lupus erythematosus patients: influence of the disease severity and therapy on the ovarian reserve","volume":"63","author":"Di Mario","year":"2019","journal-title":"Endocrine"},{"key":"2025091512551693000_7.1.e000439.11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-1235"},{"key":"2025091512551693000_7.1.e000439.12","doi-asserted-by":"publisher","DOI":"10.1002\/art.37719"},{"key":"2025091512551693000_7.1.e000439.13","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2011.650752"},{"key":"2025091512551693000_7.1.e000439.14","doi-asserted-by":"publisher","DOI":"10.1177\/0961203311409272"},{"key":"2025091512551693000_7.1.e000439.15","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/0961203317726378","article-title":"Preliminary study on the changes of ovarian reserve, menstruation, and lymphocyte subpopulation in systemic lupus erythematosus (SLE) patients of childbearing age","volume":"27","author":"Gao","year":"2018","journal-title":"Lupus"},{"key":"2025091512551693000_7.1.e000439.16","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2013.4255"},{"key":"2025091512551693000_7.1.e000439.17","doi-asserted-by":"publisher","DOI":"10.1177\/0961203315598246"},{"key":"2025091512551693000_7.1.e000439.18","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3109\/09513590.2014.922949","article-title":"Regular menstrual cycles do not rule out ovarian damage in adult women with systemic lupus erythematosus","volume":"30","author":"Malheiro","year":"2014","journal-title":"Gynecological Endocrinology"},{"key":"2025091512551693000_7.1.e000439.19","doi-asserted-by":"crossref","unstructured":"Maningding E , Dall'Era M , Trupin L , et al . Racial\/Ethnic differences in prevalence of and time to onset of SLE manifestations: the California lupus surveillance project (CLSP). Arthritis Care Res 2019.","DOI":"10.1002\/acr.23887"},{"key":"2025091512551693000_7.1.e000439.20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/art.38239","article-title":"The incidence and prevalence of systemic lupus erythematosus, 2002-2004: the Georgia lupus registry","volume":"66","author":"Lim","year":"2014","journal-title":"Arthritis & Rheumatology"},{"key":"2025091512551693000_7.1.e000439.21","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1002\/art.40191","article-title":"The incidence and prevalence of systemic lupus erythematosus in San Francisco County, California: the California lupus surveillance project","volume":"69","author":"Dall'Era","year":"2017","journal-title":"Arthritis & Rheumatology"},{"key":"2025091512551693000_7.1.e000439.22","unstructured":"1997 update of the 1982 American College of rheumatology revised criteria for classification of systemic lupus erythematosus, 1997. Available: https:\/\/www.rheumatology.org\/Portals\/0\/Files\/1997%20Update%20of%201982%20Revised.pdf [Accessed 3 Oct 2018]."},{"key":"2025091512551693000_7.1.e000439.23","doi-asserted-by":"crossref","DOI":"10.1186\/s12905-014-0149-y","article-title":"Piloting a computer assisted telephone interview: the FUCHSIA women's study","volume":"14","author":"Chin","year":"2014","journal-title":"BMC Womens Health"},{"key":"2025091512551693000_7.1.e000439.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2010.12.002"},{"key":"2025091512551693000_7.1.e000439.25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cca.2017.09.008","article-title":"Establishing age-specific reference intervals for anti-M\u00fcllerian hormone in adult Chinese women based on a multicenter population","volume":"474","author":"Cheng","year":"2017","journal-title":"Clinica Chimica Acta"},{"key":"2025091512551693000_7.1.e000439.26","doi-asserted-by":"publisher","DOI":"10.1177\/1933719115625843"},{"key":"2025091512551693000_7.1.e000439.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2012.04.013"},{"key":"2025091512551693000_7.1.e000439.28","doi-asserted-by":"publisher","DOI":"10.3109\/13697137.2014.912262"},{"key":"2025091512551693000_7.1.e000439.29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jri.2016.07.001","article-title":"Reproductive aspects of systemic lupus erythematosus","volume":"117","author":"Oktem","year":"2016","journal-title":"J Reprod Immunol"},{"key":"2025091512551693000_7.1.e000439.30","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1007\/s10067-017-3797-0","article-title":"Anti-M\u00fcllerian hormone and ovarian reserve in systemic lupus erythematosus","volume":"36","author":"Martins","year":"2017","journal-title":"Clin Rheumatol"},{"key":"2025091512551693000_7.1.e000439.31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.21037\/apm.2020.02.11","article-title":"Assessment of ovarian reserve by serum anti-M\u00fcllerian hormone in patients with systemic lupus erythematosus: a meta-analysis","volume":"9","author":"Luo","year":"2020","journal-title":"Ann Palliat Med"},{"key":"2025091512551693000_7.1.e000439.32","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.14588"},{"key":"2025091512551693000_7.1.e000439.33","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dew032"},{"key":"2025091512551693000_7.1.e000439.34","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209770"},{"key":"2025091512551693000_7.1.e000439.35","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/acr.24022","article-title":"Infertility among African American women with systemic lupus erythematosus compared to healthy women: a pilot study","volume":"72","author":"Angley","year":"2020","journal-title":"Arthritis Care Res"},{"key":"2025091512551693000_7.1.e000439.36","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.2019.19191","article-title":"Association of premature natural and surgical menopause with incident cardiovascular disease","volume":"322","author":"Honigberg","year":"2019","journal-title":"JAMA"},{"key":"2025091512551693000_7.1.e000439.37","doi-asserted-by":"crossref","DOI":"10.1186\/s13293-017-0152-8","article-title":"The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy","volume":"8","author":"Iorga","year":"2017","journal-title":"Biol Sex Differ"},{"key":"2025091512551693000_7.1.e000439.38","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-016-0762-8","article-title":"Unraveling the associations of age and menopause with cardiovascular risk factors in a large population-based study","volume":"15","author":"de Kat","year":"2017","journal-title":"BMC Med"},{"key":"2025091512551693000_7.1.e000439.39","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu222"},{"key":"2025091512551693000_7.1.e000439.40","doi-asserted-by":"publisher","DOI":"10.1002\/art.27551"},{"key":"2025091512551693000_7.1.e000439.41","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.mayocp.2019.01.044","article-title":"Systemic lupus erythematosus and increased prevalence of atherosclerotic cardiovascular disease in hospitalized patients","volume":"94","author":"Katz","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"2025091512551693000_7.1.e000439.42","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dms022"},{"key":"2025091512551693000_7.1.e000439.43","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/acr.24130","article-title":"2020 American College of rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Care Res"},{"key":"2025091512551693000_7.1.e000439.44","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.fertnstert.2018.05.034","article-title":"Fertility preservation and reproduction in patients facing gonadotoxic therapies: an ethics Committee opinion","volume":"110","year":"2018","journal-title":"Fertil Steril"},{"key":"2025091512551693000_7.1.e000439.45","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.fertnstert.2016.07.1102","article-title":"Fertility counseling and preservation practices in youth with lupus and vasculitis undergoing gonadotoxic therapy","volume":"106","author":"Nahata","year":"2016","journal-title":"Fertil Steril"},{"key":"2025091512551693000_7.1.e000439.46","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-199005000-00010"},{"key":"2025091512551693000_7.1.e000439.47","doi-asserted-by":"crossref","first-page":"5024","DOI":"10.1210\/jc.2018-02607","article-title":"Can menopause prediction be improved with multiple AMH measurements? results from the prospective Doetinchem cohort study","volume":"104","author":"de Kat","year":"2019","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Lupus Science &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/lupus-2020-000439","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T19:55:24Z","timestamp":1757966124000},"score":1,"resource":{"primary":{"URL":"https:\/\/lupus.bmj.com\/lookup\/doi\/10.1136\/lupus-2020-000439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,11,1]]},"published-print":{"date-parts":[[2020,11]]}},"alternative-id":["10.1136\/lupus-2020-000439"],"URL":"https:\/\/doi.org\/10.1136\/lupus-2020-000439","relation":{},"ISSN":["2053-8790"],"issn-type":[{"value":"2053-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11]]}}}